Metabotropic glutamate receptor 3
Metabotropic Glutamate Receptor 3[edit]
Metabotropic glutamate receptor 3 (mGlu3) is a type of G protein-coupled receptor (GPCR) that is activated by the neurotransmitter glutamate. It is one of the eight metabotropic glutamate receptors, which are divided into three groups based on their sequence homology, signal transduction mechanisms, and pharmacological properties.
Structure[edit]
Metabotropic glutamate receptor 3 is a member of the Class C GPCR family. Like other members of this family, mGlu3 has a large extracellular domain that binds glutamate, a seven-transmembrane domain that spans the cell membrane, and an intracellular domain that interacts with G proteins. The receptor is typically found as a dimer, which is important for its function.
Function[edit]
mGlu3 receptors are primarily involved in modulating synaptic transmission and neuronal excitability. They are predominantly expressed in the central nervous system, including the cerebral cortex, hippocampus, and thalamus. Activation of mGlu3 receptors can lead to the inhibition of adenylyl cyclase, resulting in decreased levels of cyclic AMP (cAMP) and modulation of various downstream signaling pathways.
Pharmacology[edit]
The pharmacological modulation of mGlu3 receptors has been of significant interest due to their potential therapeutic applications. Selective agonists and antagonists have been developed to study the receptor's function and its role in various neurological disorders. ML337 is a selective positive allosteric modulator of mGlu3, which has been used in research to explore the receptor's potential as a drug target.
Clinical Significance[edit]
mGlu3 receptors have been implicated in several neurological and psychiatric disorders, including schizophrenia, anxiety, and depression. Modulation of mGlu3 receptor activity is being investigated as a potential therapeutic strategy for these conditions. The receptor's role in neuroprotection and neuroinflammation also makes it a target of interest in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
